Biotechnology
Healthcare
Investing News
Life Style
Market News
Medical Use
Pharmaceutical
Products
The Market Buzz
Your Environment
Merck sells $952 Million of Covid-19 Treatment Pill in 4Q
Merck (NYSE: MRK) sold USD952 Million of molnupiravir, its Covid-19 treatment pill, during the fourth quarter and is set to sell an additional USD5 Billion to USD6 Billion this...